Skip to main content
Premium Trial:

Request an Annual Quote

SpeeDx RespiV PlexPlus

SpeeDx has launched the RespiV PlexPlus assay for research use only. The test uses the company's new PlexPlus technology, which allows the detection of multiple targets within each channel using standard qPCR instrumentation. This innovation comes from specialized universal probes that fluoresce in a temperature-dependent manner, with their fluorescence acquired at two temperatures across multiple wavelengths in real time, the company said. RespiV PlexPlus simultaneously detects 14 respiratory viral targets in a single well: influenza A virus; influenza B virus; SARS-CoV-2; respiratory syncytial viruses A and B; adenoviruses B and C; human parainfluenza viruses 1, 2, 3 and 4; human metapneumovirus; rhinovirus; and human enterovirus.